Study finds tocilizumab improves survival in critically ill patients with COVID-19

(Brigham and Women's Hospital) The investigators found that when tocilizumab was administered within the first two days of intensive care unit (ICU) admission, there was a 30 percent relative decrease (and a 10 percent absolute decrease) in mortality compared to patients whose treatment did not include early use of tocilizumab.

https://www.eurekalert.org/pub_releases/2020-10/bawh-sft102020.php

Source: EurekAlert! - Infectious and Emerging Diseases - October 20, 2020 Category: Infectious Diseases Source Type: news